366 related articles for article (PubMed ID: 14688707)
1. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.
Okumura M; Ohta M; Takeuchi Y; Shiono H; Inoue M; Fukuhara K; Kadota Y; Miyoshi S; Fujii Y; Matsuda H
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1922-8. PubMed ID: 14688707
[TBL] [Abstract][Full Text] [Related]
2. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
Ambrogi V; Mineo TC
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
4. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody.
Moulian N; Bidault J; Truffault F; Yamamoto AM; Levasseur P; Berrih-Aknin S
Blood; 1997 May; 89(9):3287-95. PubMed ID: 9129034
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis.
Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
Muscle Nerve; 2018 Dec; 58(6):796-800. PubMed ID: 30020542
[TBL] [Abstract][Full Text] [Related]
6. Thymectomy in late-onset myasthenia gravis.
Olanow CW; Lane RJ; Roses AD
Arch Neurol; 1982 Feb; 39(2):82-3. PubMed ID: 7059304
[TBL] [Abstract][Full Text] [Related]
7. Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.
Fujii Y; Hayakawa M; Nakahara K
J Neurol; 1992 Feb; 239(2):82-8. PubMed ID: 1552308
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.
Bartoccioni E; Scuderi F; Scoppetta C; Evoli A; Tonali P; Guidi L; Bartoloni C; Terranova T
J Neurol; 1980; 224(1):9-15. PubMed ID: 6157802
[TBL] [Abstract][Full Text] [Related]
9. Long-term change of anti-acetylcholine receptor antibody in patients with myasthenia gravis after thymectomy.
Hayashi M; Manabe K; Takaoka T; Yamada I; Kida K; Matsuda H; Yoshinaga J
Acta Paediatr Jpn; 1995 Jun; 37(3):362-6. PubMed ID: 7645389
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis.
Pompeo E; Tacconi F; Massa R; Mineo D; Nahmias S; Mineo TC
Eur J Cardiothorac Surg; 2009 Jul; 36(1):164-9. PubMed ID: 19339195
[TBL] [Abstract][Full Text] [Related]
11. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy.
Oosterhuis HJ; Limburg PC; Hummel-Tappel E; Van den Burg W; The TH
J Neurol Sci; 1985 Jul; 69(3):335-43. PubMed ID: 4031948
[TBL] [Abstract][Full Text] [Related]
12. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
13. Effects of preoperative duration of symptoms on patients with myasthenia gravis.
Monden Y; Nakahara K; Kagotani K; Fujii Y; Nanjo S; Masaoka A; Kawashima Y
Ann Thorac Surg; 1984 Sep; 38(3):287-91. PubMed ID: 6476952
[TBL] [Abstract][Full Text] [Related]
14. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
[TBL] [Abstract][Full Text] [Related]
15. Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.
Seybold ME; Baergen RN; Nave B; Lindstrom JM
Br Med J; 1978 Oct; 2(6144):1051-3. PubMed ID: 709215
[TBL] [Abstract][Full Text] [Related]
16. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
17. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.
Newsom-Davis J; Willcox N; Calder L
N Engl J Med; 1981 Nov; 305(22):1313-8. PubMed ID: 7290153
[TBL] [Abstract][Full Text] [Related]
18. In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis.
Vincent A; Scadding GK; Thomas HC; Newsom-Davis J
Lancet; 1978 Feb; 1(8059):305-7. PubMed ID: 75339
[TBL] [Abstract][Full Text] [Related]
19. Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis.
Kagotani K; Monden Y; Nakahara K; Fujii Y; Seike Y; Kitamura S; Masaoka A; Kawashima Y
J Thorac Cardiovasc Surg; 1985 Jul; 90(1):7-12. PubMed ID: 4010323
[TBL] [Abstract][Full Text] [Related]
20. In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes.
Katzberg HD; Aziz T; Oger J
J Neurol Sci; 2002 Oct; 202(1-2):77-83. PubMed ID: 12220697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
